DS
TRIB

David Shaw’s Trinity Biotech TRIB Stock Holding History

David Shaw’s Portfolio TRIB Stock Details TRIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-464
Closed -$348K – 3985
2018
Q2 		$348K Hold
464
– – ﹤0.01% 3301
2018
Q1 		$358K Hold
464
– – ﹤0.01% 3057
2017
Q4 		$356K Sell
464
-793
-63% -$613K ﹤0.01% 3161
2017
Q3 		$1.06M Sell
1,257
-1,156
-48% -$967K ﹤0.01% 2458
2017
Q2 		$2.17M Sell
2,413
-3
-0.1% -$2.55K ﹤0.01% 1922
2017
Q1 		$2.16M Buy
2,416
+483
+25% +$453K ﹤0.01% 1793
2016
Q4 		$2.01M Buy
1,933
+1,481
+328% +$1.53M ﹤0.01% 2004
2016
Q3 		$896K Buy
452
+46
+11% +$85.9K ﹤0.01% 2458
2016
Q2 		$691K Buy
406
+113
+39% +$191K ﹤0.01% 2632
2016
Q1 		$513K Buy
293
+179
+157% +$285K ﹤0.01% 2771
2015
Q4 		$202K Sell
114
-154
-57% -$273K ﹤0.01% 3558
2015
Q3 		$460K Sell
268
-39
-13% -$94.1K ﹤0.01% 3116
2015
Q2 		$833K Buy
307
+98
+47% +$255K ﹤0.01% 2832
2015
Q1 		$604K Buy
209
+127
+155% +$352K ﹤0.01% 2941
2014
Q4 		$214K Sell
82
-162
-66% -$419K ﹤0.01% 3780
2014
Q3 		$668K Sell
244
-115
-32% -$374K ﹤0.01% 3134
2014
Q2 		$1.24M Buy
359
+107
+42% +$380K ﹤0.01% 2737
2014
Q1 		$917K Buy
252
+89
+55% +$350K ﹤0.01% 3111
2013
Q4 		$615K Buy
163
+15
+10% +$54K ﹤0.01% 3568
2013
Q3 		$482K Sell
148
-251
-63% -$734K ﹤0.01% 3602
2013
Q2 		$1.01M Buy
+399
New +$993K ﹤0.01% 2704

Other funds holding TRIB

PIM
Paradice Investment Management Denver, Colorado $627M AUM 43.41% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $114B AUM 41.71% 1-Year Est. Return
LAM
Lapides Asset Management Greenwich, Connecticut $153M AUM 9.03% 1-Year Est. Return
FWSM
First Wilshire Securities Management Pasadena, California $486M AUM 50.29% 1-Year Est. Return
SM
Senvest Management New York $3.41B AUM 66.27% 1-Year Est. Return
2L
22NW LP Seattle, Washington $105M AUM 38.33% 1-Year Est. Return
SCM
Stonehill Capital Management New York $350M AUM 73.6% 1-Year Est. Return
HAIM
Hunter Associates Investment Management Pittsburgh, Pennsylvania $868M AUM 32.25% 1-Year Est. Return
HA
Heartland Advisors Milwaukee, Wisconsin $2.25B AUM 44.61% 1-Year Est. Return

David Shaw's TRIB Position: Q3 2018 in Review

David Shaw sold out of Trinity Biotech (TRIB) in Q3 2018, closing a stake of 464 shares — an estimated $348K sold.

David Shaw first reported a position in TRIB in Q2 2013 and held it in 21 quarters. The position peaked at $2.17M in Q2 2017. 45 funds tracked by Wall St. Rank hold TRIB as of Q3 2018.

  • David Shaw reported no remaining Trinity Biotech position as of Q3 2018 after selling out during the quarter.
  • David Shaw sold 464 Trinity Biotech shares in Q3 2018, an estimated $348K.
  • David Shaw first reported a position in Trinity Biotech in Q2 2013 and held it in 21 quarters.
  • David Shaw's Trinity Biotech position peaked at $2.17M in Q2 2017.
  • 45 funds tracked by Wall St. Rank held Trinity Biotech as of Q3 2018.

Based on D.E. Shaw & Co's 13F filing for Q3 2018, filed 14 Nov 2018.